- English
- Español
- Português
- русский
- Français
- 日本語
- Deutsch
- tiếng Việt
- Italiano
- Nederlands
- ภาษาไทย
- Polski
- 한국어
- Svenska
- magyar
- Malay
- বাংলা ভাষার
- Dansk
- Suomi
- हिन्दी
- Pilipino
- Türkçe
- Gaeilge
- العربية
- Indonesia
- Norsk
- تمل
- český
- ελληνικά
- український
- Javanese
- فارسی
- தமிழ்
- తెలుగు
- नेपाली
- Burmese
- български
- ລາວ
- Latine
- Қазақша
- Euskal
- Azərbaycan
- Slovenský jazyk
- Македонски
- Lietuvos
- Eesti Keel
- Română
- Slovenski
- मराठी
- Srpski језик
New Products
Sinae intermedia Factory
Sandoo anno 2009 stabilivit, copiam facultatis a R&D gubernatore ad scalam mercatoriam formavimus., inter API, anti-cancer, intermedia medicamenta antiviralia, oeconomiae subtilia, cibaria additiva, necnon clavis media mixtorum polypeptidorum in facie biopharmaceuticorum in mundus.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
- View as
![Spiro[cyclohexane-1,9'(6'H)-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidine]-7'(8'H)-acidi carboxylici, 2' -(methylthio)-6'-oxo-, 1,1-dimethylethyl ester](/upload/6698/spiro-cyclohexane-1-9-6-h-pyrazino-1-2-1-5-pyrrolo-2-3-d-pyrimidine-7-8-h-carboxylic-acid-2-methylthio-6-oxo-1-1-dimethylethyl-ester_486295.gif "Spiro[cyclohexane-1,9'(6'H)-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidine]-7'(8'H)-acidi carboxylici, 2' -(methylthio)-6'-oxo-, 1,1-dimethylethyl ester")
Spiro[cyclohexane-1,9'(6'H)-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidine]-7'(8'H)-acidi carboxylici, 2' -(methylthio)-6'-oxo-, 1,1-dimethylethyl ester
Product Name:Spiro[cyclohexane-1,9'(6'H)-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidine]-7'(8'H)-acidi carboxylici , 2'- (methylthio) -6'- oxo-, 1,1-dimethylethylus
Formulae hypotheticae: C20H26N4O3S
Molecular pondus:402.51
CAS Subcriptio Number:2170746-99-1
1-METHYL-4-(6-AMINOPYRIDIN-3-YL)PIPERAZINE
Product Name: 1-METHYL-4-(6-AMINOPYRIDIN-3-YL)PIPERAZINE
Formulae hypotheticae: C10H16N4
Molecular pondus:192.26
CAS Registry Number: 571189-49-6
1-(((2R,3S)-2-(2,5-difluorophenyl)-3-Methyloxiran-2-yl)Methyl)-1H-1,2,4-triazole
Product Name:1-((2R,3S)-2-(2,5-difluorophenyl)-3-Methyloxiran-2-yl)Methyl)-1H-1,2,4-triazole
Formulae hypotheticae: C12H11F2N3O
Molecular pondus:251.23
CAS Subcriptio Number:241479-73-2
4-(2-Bromoacetyl) benzonitrile
Product Name:4-(2-Bromoacetyl) benzonitrile
Formulae hypotheticae: C9H6BrNO
Molecular Weight:224.05
CAS Subcriptio Number:20099-89-2
![Glycine, N-[(1,1-diMethylethoxy)carbonyl]-N-Methyl-, [2-[[[(1-chloroethoxy)carbonyl]MethylaMino]-3-pyridinyl]Methyl ester](/upload/6698/glycine-n-1-1-dimethylethoxy-carbonyl-n-methyl-2-1-chloroethoxy-carbonyl-methylamino-3-pyridinyl-methyl-ester_337893.gif "Glycine, N-[(1,1-diMethylethoxy)carbonyl]-N-Methyl-, [2-[[[(1-chloroethoxy)carbonyl]MethylaMino]-3-pyridinyl]Methyl ester")
Glycine, N-[(1,1-diMethylethoxy)carbonyl]-N-Methyl-, [2-[[[(1-chloroethoxy)carbonyl]MethylaMino]-3-pyridinyl]Methyl ester
Product Name:Glycine, N-[(1,1-diMethylethoxy)carbonyl-N-Methyl-, [2-[[(1-chloroethoxy)carbonyl]MethylaMino]-3-pyridinyl]Methyl ester
Formulae hypotheticae: C18H26ClN3O6
Molecular pondus:415.87
CAS Registry Number: 338990-31-1
(2R,3R)-3-(2,5-Difluorophenyl) -3-hydroxy-2-Methyl-4-(1H-1,2,4-triazol-1-yl)thiobutyraMide
Product Name:(2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-Methyl-4-(1H-1,2,4-triazol-1-yl)thiobutyraMide
Formulae hypotheticae: C13H14F2N4OS
Molecular pondus:312.34
CAS Registry Number:368421-58-3
Sandoo magnus intermedia fabrica et praebitus in Sinis est. Officina nostra in intermedia exportare et importare plus quam 10 annos posita est, et fructus nostri toto orbe terrarum operiuntur, ut Civitates Foederatae, Canada, Britanniarum Regnum, Franciae, etc., paulatim plus quam XX operiunt. terris per orbem.
